Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-16

FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for NEVIRAPINE by Aurobindo Pharma Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)